
A Look Inside a DEA Investigation and Prosecution of Opioid Prescribing and the Controlled Substances Act: The Opioid Odyssey and the Aftermath of Bad Decisions
Panelists; comprised of a former DEA Diversion Investigator, an Assistant United States Attorney and a Clinic Director of an Opiate treatment Program; will discuss the investigations involving the illicit distribution of pharmaceutical controlled substances, the regulatory landscape for prescribing and dispensing controlled substances, and treatment interventions to reduce many of the consequences brought on by the opioid epidemic.